Maria Chiara T.
- Country
- Italy
- Department
- Oncology Unit
Research Overview
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
- Phase II Open-Label Study on Sonidegib Compliance in Locally Advanced Basal Cell Carcinoma Patients with Complete Response
- Phase 3 Evaluation of Fianlimab and Cemiplimab Versus Pembrolizumab in Treatment-Naïve Unresectable Locally Advanced or Metastatic Melanoma
Data & Insights
Has run more than one trial at 102 of 234 partner sites.
Specializations
Melanoma Research
This investigator specializes in the treatment of advanced melanoma, with particular focus on both resectable and unresectable cases. Their research encompasses innovative therapeutic approaches for various stages of the disease, from stage 3 to metastatic conditions.
- Resectable Stage 3-4 Melanoma Treatment
- Metastatic Melanoma Management
- Post-surgical Recurrence Prevention
Their work involves evaluation of combination immunotherapy approaches and novel treatment strategies for melanoma patients.
Immunotherapy Development
The investigator focuses on advancing immunotherapy treatments, particularly studying novel therapeutic combinations and comparing their efficacy with established treatments. Their research includes evaluation of biosimilar therapeutics and their integration into existing treatment protocols.
- Combination Immunotherapy Assessment
- Comparative Treatment Studies
- Biosimilar Validation Research
Their work emphasizes the development of more effective immunotherapy strategies for cancer treatment.
Skin Cancer Therapeutics
The investigator's expertise extends to the treatment of basal cell carcinoma, with specific interest in developing improved treatment regimens for locally advanced cases. Their research includes optimization of targeted therapies and investigation of Hedgehog pathway inhibitors.
- Advanced Basal Cell Carcinoma Treatment
- Treatment Compliance Studies
- Targeted Therapy Optimization
Their research aims to enhance treatment adherence and outcomes in skin cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.